References Yongjie Ma, Mingming Gao, & Dexi Liu
Over one year, liraglutide did not significantly improve the primary endpoint (change in cerebral glucose metabolic rate in certain brain regions), but secondary endpointsincluding brain volume loss, and cognitive measuresshowed benefit: ~50% less loss in several brain regions compared to placebo
25 (13), 35543563e4 (2018) T
Whilst this tablet is approved for use in the UK, it is not available currently via the NHS
Insulin is produced in the pancreas, and more insulin is produced if glucose levels are high to mop up the excess sugar, while less insulin is produced when glucose levels are low
Use this sugar-free, gluten-free, and low-calorie supplement to unleash your potential